pharmaceuticals News of 10/14/19
Ginkgo Bioworks’ Dev Shop For Genetic Programming Is Now Worth $4 Billion
Ginkgo Bioworks is now worth $4 billion after a $290 million capital infusion that will give the company the cash to dramatically expand its developer shop for genetic programming. The Boston-based company is one of a handful of U.S.-based ...
Cannabis Processing Startups Hope To Unlock New Chemicals And Treatments
Jeff Ubersax knows yeast. The chief executive officer of Demetrix studied yeast genetics and biochemistry in school and was an early employee at Amyris Biotechnologies, a technology company that was using fermentation to make biofuels back in the ...
IBM, KPMG, Merck, Walmart Team Up For Drug Supply Chain Blockchain Pilot
IBM announced its latest blockchain initiative today. This one is in partnership with KPMG, Merk and Walmart to build a drug supply chain blockchain pilot. These four companies are coming to together to help come up with a solution to track ...
Two Former Members Of Google’S Skunkworks Division Have Launched A Biomanufacturing Company
Biomanufacturing technologies — taking modified versions of existing organisms and bending them to the will of humans — has moved from the world of science fiction to becoming a new reality. Across the startup landscape companies are ...